Obstetric and Gynecologic Imaging

What Is the Best Initial Imaging for a Suspected Adnexal Mass Without Acute Symptoms?

·
What Is the Best Initial Imaging for a Suspected Adnexal Mass Without Acute Symptoms?

A 48-year-old premenopausal woman presents for her annual exam. She feels well, with no new complaints. On bimanual pelvic exam, you palpate a subtle, non-tender fullness in the left adnexa. She has no pain, fever, or other acute symptoms, but the finding is new. You are now faced with the decision of how to begin the imaging workup for this clinically suspected adnexal mass. This article provides a focused, in-depth guide to the American College of Radiology (ACR) Appropriateness Criteria for this specific scenario: the initial imaging of a suspected adnexal mass in an adult female with no acute symptoms. According to the ACR, a US duplex Doppler pelvis is Usually Appropriate as the first-line imaging study.

Who Fits This Clinical Scenario for a Suspected Adnexal Mass?

This guidance applies to a specific and common clinical situation: an adult female, either premenopausal or postmenopausal, who has a suspected adnexal mass based on clinical findings but lacks acute symptoms. The suspicion may arise from a palpable mass on a bimanual exam, as in the opening vignette, or as an incidental notation during an exam for an unrelated issue. The key inclusion criterion is the absence of an acute presentation—the patient does not have severe pelvic pain, fever, signs of hemodynamic instability, or other symptoms suggesting an urgent process like ovarian torsion, ectopic pregnancy, abscess, or cyst rupture.

It is critical to distinguish this scenario from others that require a different diagnostic approach. This workflow is NOT for:

  • Patients with acute pelvic pain: A patient presenting with sudden, severe pain may have ovarian torsion or a ruptured hemorrhagic cyst, which constitutes a surgical emergency and alters the imaging and management priorities.
  • Patients who have already had initial imaging: If a pelvic ultrasound has already been performed and the mass is characterized as indeterminate or suspicious, the patient moves into a different clinical variant. The question is no longer “what to order first,” but rather “what to do next.”
  • Pregnant patients: While ultrasound is also the primary modality in pregnancy, the differential diagnosis and management considerations for an adnexal mass are distinct.

This article focuses exclusively on the initial, non-acute workup.

What Diagnoses Are You Working Up with Initial Adnexal Imaging?

When ordering the initial imaging for a non-acute adnexal mass, the goal is to characterize the finding and narrow a broad differential. The possibilities range from benign, transient findings to serious malignancies.

A primary consideration, especially in premenopausal women, is a functional or physiologic ovarian cyst. These include follicular cysts and corpus luteum cysts, which are byproducts of the normal menstrual cycle. They are the most common cause of an adnexal mass in this population, are almost always benign, and frequently resolve on their own over one or two cycles.

The next category includes benign neoplasms, which do not resolve spontaneously but are not cancerous. This group is diverse and includes mature cystic teratomas (dermoid cysts), which can contain various tissue types like fat, hair, or teeth; cystadenomas (serous or mucinous), which are fluid-filled tumors arising from the ovarian surface; and endometriomas (“chocolate cysts”), which occur in patients with endometriosis. Non-ovarian structures like pedunculated uterine fibroids, hydrosalpinges (fluid-filled fallopian tubes), and paraovarian cysts can also mimic an ovarian mass on physical exam.

Finally, the most consequential diagnosis to exclude is ovarian malignancy. While less common than benign findings, ovarian cancer is a leading cause of gynecologic cancer death, often because it is asymptomatic in its early stages. The risk increases with age, making this a critical consideration in any postmenopausal woman with a newly detected adnexal mass. Initial imaging plays a vital role in risk stratification by identifying features suspicious for cancer.

Why Is Pelvic Ultrasound the Recommended Initial Study for a Suspected Adnexal Mass?

The ACR rates all forms of pelvic ultrasound—including transabdominal, transvaginal, a combination of both, and duplex Doppler—as Usually Appropriate for the initial evaluation of a suspected adnexal mass. This strong recommendation is based on the modality’s high diagnostic accuracy, safety profile, and accessibility.

Ultrasound provides excellent soft-tissue resolution, allowing for detailed characterization of an adnexal mass. It can reliably distinguish simple, thin-walled, anechoic cysts (which are overwhelmingly benign) from complex masses with features like thick walls, septations, or solid components. The combination of transabdominal and transvaginal approaches offers a comprehensive evaluation; the transabdominal view provides a wider field of view of the entire pelvis, while the transvaginal approach yields higher-resolution images of the ovaries and uterus.

The addition of US duplex Doppler pelvis is particularly valuable for risk stratification. Doppler imaging assesses blood flow within the mass. The absence of internal blood flow in a simple cyst is a reassuring feature. Conversely, the presence of low-resistance, high-velocity blood flow within a solid component of a mass is a concerning feature that raises suspicion for malignancy, as tumors often induce neovascularity.

Crucially, ultrasound involves no ionizing radiation (0 mSv), a significant advantage, particularly for premenopausal women who may require follow-up imaging.

In contrast, other powerful imaging modalities are not recommended for the initial workup:

  • CT pelvis with IV contrast is rated Usually not appropriate. While useful for cancer staging or in acute abdominal pain, CT exposes the patient to significant ionizing radiation (☢☢☢ 1-10 mSv) and offers inferior characterization of ovarian and endometrial detail compared to ultrasound.
  • MRI pelvis without and with IV contrast is rated May be appropriate. MRI is an exceptional problem-solving tool for adnexal masses that remain indeterminate after ultrasound. However, its higher cost, longer acquisition time, and lower availability make it unsuitable as a first-line screening test for a clinically suspected mass. Its role is in clarifying ambiguity, not initial detection.

What’s the Next Step After a Pelvic Ultrasound for an Adnexal Mass?

The results of the initial pelvic ultrasound will guide the subsequent clinical workflow, which often routes the patient to a different ACR scenario.

If the ultrasound reveals a clearly benign finding:
For a premenopausal patient with a simple cyst less than 5 cm, no further immediate action is typically needed. For larger simple cysts (5-7 cm), a follow-up ultrasound in several months is often recommended to ensure stability or resolution. This places the patient in the “Adnexal mass, likely benign, no acute symptoms. Premenopausal. Follow-up imaging” scenario. For postmenopausal women, even small simple cysts may warrant follow-up imaging to ensure stability, routing them to the corresponding postmenopausal follow-up scenario.

If the ultrasound finding is indeterminate:
Sometimes a mass has complex features that are neither clearly benign nor definitively malignant (e.g., a unilocular cyst with a small, non-vascular solid nodule). In this situation, further characterization is necessary. This is the primary indication for pelvic MRI, which can better characterize tissue types (e.g., identify fat in a dermoid or blood products in an endometrioma). This moves the patient to the “Adnexal mass, indeterminate on initial pelvic US… Next” scenario, where MRI is a top-rated study.

If the ultrasound is suspicious for malignancy:
If the mass demonstrates features highly concerning for cancer—such as a large solid component with central blood flow, thick irregular septations, papillary projections, or associated findings like ascites or peritoneal nodules—the next step is not simply more imaging. The patient requires an urgent referral to a gynecologic oncologist for surgical evaluation. Further imaging, such as a CT of the abdomen and pelvis, may be ordered by the specialist for staging purposes, but the critical action is the clinical handoff. This aligns with the “Adnexal mass, suspicious for malignancy on pelvic US…” scenario.

Pitfalls to Avoid (and When to Get Help)

In the initial workup of a suspected adnexal mass, several common pitfalls can delay diagnosis or lead to unnecessary testing.

First, avoid ordering CT as the initial imaging test. It provides less detail of the adnexa than ultrasound and exposes the patient to unnecessary radiation. Second, do not dismiss a new adnexal mass in a postmenopausal woman, even if it is small and simple-appearing on exam; it warrants a full imaging evaluation with ultrasound. Third, remember that a “normal” CA-125 level does not exclude ovarian cancer, especially in early-stage disease, and should not be used to bypass imaging. Finally, failing to obtain both transabdominal and transvaginal views can lead to an incomplete assessment, as some large masses are not fully visualized with the transvaginal probe alone.

If an ultrasound report returns with features highly suspicious for malignancy (e.g., O-RADS 5), the situation requires prompt escalation. The appropriate next step is an immediate referral to a gynecologic oncologist.

Related ACR Topics and Tools

This article covers one specific clinical variant. For a comprehensive overview of all related scenarios, from follow-up of benign cysts to workup of indeterminate masses, please consult the parent topic article. The tools below can assist in navigating other clinical questions and understanding imaging protocols.

Frequently Asked Questions

Is a transabdominal ultrasound alone sufficient for an initial evaluation?

While a transabdominal ultrasound is rated as *Usually Appropriate*, a combined transabdominal and transvaginal exam is generally preferred. The transabdominal view provides a broad overview of the pelvis, which is useful for very large masses that may extend beyond the field of view of a transvaginal probe. The transvaginal view provides higher-resolution images of the ovaries, endometrium, and adnexal structures, allowing for more detailed characterization. Ordering both is standard practice for a complete evaluation.

Should I order a CA-125 blood test along with the initial ultrasound?

The role of CA-125 as a screening tool in this initial scenario is limited. It has low sensitivity for early-stage ovarian cancer and low specificity, as it can be elevated by many benign conditions (e.g., endometriosis, fibroids, menstruation, pelvic inflammatory disease). While it may be ordered as part of the workup, it should not replace or delay imaging. Its primary utility is in postmenopausal women with a suspicious mass or for monitoring treatment response in known cancer.

What if the patient is postmenopausal? Does that change the initial imaging choice?

No, the initial imaging choice remains the same. Pelvic ultrasound is still the *Usually Appropriate* first step for a suspected adnexal mass in a postmenopausal woman. However, the interpretation and downstream management may differ. Any new mass, particularly one with solid or complex features, is more suspicious in a postmenopausal patient, as physiologic cysts should not be forming. This increases the urgency of a definitive diagnosis and may lead more quickly to specialist referral.

Why is MRI only ‘May be appropriate’ and not the first choice?

MRI is an excellent problem-solving modality for adnexal masses, but it is not the ideal *initial* test. Ultrasound is faster, more widely available, less expensive, and highly effective at characterizing the majority of adnexal masses as either clearly benign or suspicious. MRI is reserved for cases where the ultrasound is indeterminate, meaning the nature of the mass cannot be confidently determined. Using it as the first-line test for every suspected mass would be an inefficient use of resources.

If the ultrasound is normal but I still have a high clinical suspicion, what should I do?

If there is a strong discrepancy between a high-suspicion physical exam and a normal ultrasound report, the first step is to ensure the ultrasound was technically adequate and complete. Consider a direct conversation with the radiologist to review the images. If suspicion remains high, options include a repeat ultrasound after the next menstrual cycle (in premenopausal women) to see if a transient finding has resolved, or proceeding to a problem-solving MRI, especially if the patient has significant risk factors for malignancy.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 30, 2026